Newsroom
Sorted by: Latest
-
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer
WHIPPANY, N.J.--(BUSINESS WIRE)--AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with mCSPC...
-
Titan SA : Résultats de l’Assemblée Générale Annuelle des Actionnaires
BRUXELLES--(BUSINESS WIRE)--Regulatory News: Titan S.A. (Euronext Brussels, Paris and Euronext Athens, TITC) annonce que son Assemblée Générale Annuelle des Actionnaires, tenue le 8 mai 2026, a approuvé l’ensemble des points inscrits à l’ordre du jour, notamment : la distribution d’un dividende brut de €1,10 par action : Détachement du dividende: 1 juillet 2026 Enregistrement du dividende: 2 juillet 2026 Paiement du dividende: 7 juillet 2026 le renouvellement et la nomination des membres du Con...
-
Titan SA: Results of the Annual General Meeting of Shareholders
BRUSSELS--(BUSINESS WIRE)--Regulatory News: Titan SA (Euronext Brussels, Paris and Euronext Athens, TITC) announces that its Annual General Meeting of Shareholders, held on 8 May 2026, approved all items on the agenda, including: the distribution of a gross dividend of €1.10 per share. Ex-dividend date: 1 July 2026 Record date: 2 July 2026 Payment date: 7 July 2026 the renewal and appointment of members of the Board of Directors for a term of one year, as follows: Dimitri Papalexopoulos, Non-ex...
-
Estudio de Canva: los líderes de marketing apuestan por la IA para el trabajo creativo, pero la confianza de los consumidores es el nuevo campo de batalla
SAN FRANCISCO--(BUSINESS WIRE)--Canva, la plataforma de comunicación visual líder a nivel mundial, publicó el día de hoy la tercera edición de su informe "The State of Marketing and AI", en el que se pone de manifiesto una tensión fundamental en el marketing actual: la IA está permitiendo alcanzar una velocidad y una escala sin precedentes, pero tanto los profesionales de marketing como los consumidores se enfrentan al reto de cómo equilibrar esa velocidad con la autenticidad. El estudio, que s...
-
CORRECTING and REPLACING PGIM Closed-End Funds declare distributions for March, April and May 2026
NEWARK, N.J.--(BUSINESS WIRE)--May monthly distribution payable date of release issued February 27, 2026, should read: 5/29/2026 (instead of 5/31/2026). The updated release reads: PGIM CLOSED-END FUNDS DECLARE DISTRIBUTIONS FOR MARCH, APRIL AND MAY 2026 PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY) and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) declared today monthly distributions for March, April and May 2026. The distribution am...
-
Eucatex, presidida por Flávio Maluf, é eleita Melhor Indústria de Tintas Imobiliárias na 30ª edição do Prêmio Paint & Pintura
SÃO PAULO--(BUSINESS WIRE)--A Eucatex se destacou como uma das principais vencedoras da 30ª edição do Prêmio Paint & Pintura, realizada em 8 de maio de 2026 no Espaço Vila dos Ipês, em São Paulo. A companhia foi reconhecida em três categorias, incluindo o título de Melhor Indústria de Tintas Imobiliárias, consolidando sua posição de referência no setor. Promovida pela Agnelo Editora e Eventos, a premiação abrangeu 54 categorias nesta edição comemorativa, que marca três décadas de valorizaçã...
-
ICUS Commends New Proposal Supporting CEUS Training for Sonographers
CHICAGO--(BUSINESS WIRE)--New standards proposed by CAAHEP will require students at accredited sonography training programs to demonstrate knowledge of CEUS....
-
Macy’s, Inc. Board of Directors Declares Quarterly Dividend
NEW YORK--(BUSINESS WIRE)--Macy’s, Inc. Board of Directors Declares Quarterly Dividend...
-
Xtrackers (IE) plc UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 14 May 2026 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Company...
-
Secretome Therapeutics Announces Participation in Upcoming Summer Investor Conferences
PLANO, Texas--(BUSINESS WIRE)--Secretome Therapeutics, a clinical-stage biotechnology company developing novel cellular and cell-based therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced that members of its management team will participate in three upcoming investor conferences this summer. Secretome is scheduled to attend the following conferences: Jefferies Global Healthcare Conference June 2 – 4, 2026 New York, New York Oppenheimer CNS & Neuro-Muscular Summi...